These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1318047)

  • 1. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
    Giembycz MA
    Biochem Pharmacol; 1992 May; 43(10):2041-51. PubMed ID: 1318047
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs.
    Santing RE; Olymulder CG; Van der Molen K; Meurs H; Zaagsma J
    Eur J Pharmacol; 1995 Feb; 275(1):75-82. PubMed ID: 7774665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 inhibitors: antiinflammatory therapy for chronic obstructive pulmonary disease at last?
    Kerstjens HA; Timens W
    Am J Respir Crit Care Med; 2003 Oct; 168(8):914-5. PubMed ID: 14555456
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.
    Nicholson CD; Shahid M
    Pulm Pharmacol; 1994 Feb; 7(1):1-17. PubMed ID: 8003849
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs.
    Spina D; Landells LJ; Page CP
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():24-34. PubMed ID: 9756183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 7. Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
    Schudt C; Winder S; Eltze M; Kilian U; Beume R
    Agents Actions Suppl; 1991; 34():379-402. PubMed ID: 1665311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
    Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
    Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analogues.
    Ashton MJ; Cook DC; Fenton G; Karlsson JA; Palfreyman MN; Raeburn D; Ratcliffe AJ; Souness JE; Thurairatnam S; Vicker N
    J Med Chem; 1994 May; 37(11):1696-703. PubMed ID: 8201604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs.
    Manabe H; Akuta K; Okamura K; Ohmori K
    Int Arch Allergy Immunol; 1997 Dec; 114(4):389-99. PubMed ID: 9414145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?
    Giembycz MA
    Drugs; 2000 Feb; 59(2):193-212. PubMed ID: 10730545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new chemical tool for exploring the role of the PDE4D isozyme in leukocyte function.
    Chambers RJ; Abrams K; Castleberry TA; Cheng JB; Fisher DA; Kamath AV; Marfat A; Nettleton DO; Pillar JD; Salter ED; Sheils AL; Shirley JT; Turner CR; Umland JP; Lam KT
    Bioorg Med Chem Lett; 2006 Feb; 16(3):718-21. PubMed ID: 16263279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?
    Townley RG
    J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors.
    Nakata A; Ogawa K; Sasaki T; Koyama N; Wada K; Kotera J; Kikkawa H; Omori K; Kaminuma O
    Clin Exp Immunol; 2002 Jun; 128(3):460-6. PubMed ID: 12067300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective phosphodiesterase type 4 inhibitors reduce the prolonged survival of eosinophils stimulated by granulocyte-macrophage colony-stimulating factor.
    Takeuchi M; Tatsumi Y; Kitaichi K; Baba K; Suzuki R; Shibata E; Takagi K; Miyamoto K; Hasegawa T; Takagi K
    Biol Pharm Bull; 2002 Feb; 25(2):184-7. PubMed ID: 11853162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of selective phosphodiesterase 3 inhibition on the early and late asthmatic responses to inhaled allergen.
    Bardin PG; Dorward MA; Lampe FC; Franke B; Holgate ST
    Br J Clin Pharmacol; 1998 Apr; 45(4):387-91. PubMed ID: 9578187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase inhibitors.
    Boswell-Smith V; Spina D; Page CP
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.
    Shepherd MC
    Pulm Pharmacol Ther; 2006; 19(1):24-31. PubMed ID: 16046159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.